Onconetix Inc (ONCO): THANKS, Bro!! However, I already bought-...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	194
Posts	11393
Boards Moderated	2
Alias Born	06/20/2022

Invest-in-America

Re: INFINITI post# 142

Wednesday, 08/17/2022 2:12:31 PM

Wednesday, August 17, 2022 2:12:31 PM

THANKS, Bro!! However, I already bought-&-dumped @EAR, today, for a REASONABLE profit; can't keep PACE with the (new) volatile NASDAQ anymore, these days!! Hell, the NASDAQ has become the new (scandalous) OTC!!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ONCO News

Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 09:20:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:45:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 03:50:30 PM
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders • GlobeNewswire Inc. • 09/20/2024 03:45:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/03/2024 07:11:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 07:10:25 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/29/2024 11:38:07 AM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:16:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:05:28 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/01/2024 08:05:12 PM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 07/22/2024 09:00:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:04:39 AM
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds • GlobeNewswire Inc. • 07/15/2024 10:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 12:31:06 PM
Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds • GlobeNewswire Inc. • 07/11/2024 12:17:00 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/14/2024 09:09:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:35:33 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:05:48 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:05:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:45:43 PM
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors • GlobeNewswire Inc. • 02/13/2024 11:00:00 AM
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™ • GlobeNewswire Inc. • 12/18/2023 12:00:00 PM

More ONCO News

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover